# Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

> **NCT00797953** · PHASE2 · COMPLETED · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 124 (actual)

## Conditions studied

- Angina Pectoris

## Interventions

- **DRUG:** T89

## Key facts

- **NCT ID:** NCT00797953
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797953, "Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00797953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*